Mexico fast-track medical device registration now operational: 30-day COFEPRIS pathway

/ Mexico - COFEPRIS, Regulatory updates / By

Date: March 4, 2026

Mexico has begun operational implementation of its fast-track pathway for medical device registration, allowing eligible products to obtain approval in as little as 30 business days.

Although the regulatory framework was introduced in 2025, the pathway is only now becoming fully operational, creating new opportunities for manufacturers seeking faster entry into the Mexican healthcare market.

The fast-track mechanism was introduced through an agreement published in the Diario Oficial de la Federación on July 18, 2025, establishing an abbreviated regulatory pathway based on international regulatory reliance.

The regulation entered into force on September 1, 2025, but the 30-business-day approval timeline is only now starting to materialize in practice, as procedures and submission requirements become clearer for manufacturers and regulatory representatives.

What is the Mexico fast-track medical device registration pathway?

The Mexico fast-track medical device registration pathway is an accelerated process implemented by the Federal Commission for the Protection against Sanitary Risks allowing medical devices already approved by trusted international regulators to obtain Mexican registration in approximately 30 business days.

The mechanism relies on recognition of approvals from authorities participating in the International Medical Device Regulators Forum (IMDRF).

This approach reflects a broader global trend toward regulatory reliance, where health authorities use scientific evaluations conducted by trusted regulatory agencies to streamline market access procedures.

Manufacturers considering expansion into the region often integrate this pathway as part of their broader Latin American regulatory strategy, particularly when entering the Mexican medical device market.

 

 

Which medical devices qualify for the COFEPRIS fast-track pathway?

Medical devices may qualify for the accelerated pathway if they already hold regulatory approval from an authority belonging to the IMDRF regulatory network.

Recognized jurisdictions include:

  • United States
  • European Union
  • Brazil
  • Canada
  • Japan
  • Australia
  • United Kingdom
  • Switzerland
  • Singapore
  • South Korea
  • China
  • Russia

For companies already commercializing their devices in these jurisdictions, the pathway can significantly reduce regulatory timelines for market entry into Mexico.

Key requirements for the 30-day registration pathway

To benefit from the accelerated process, manufacturers must demonstrate full equivalence between the device approved by the reference authority and the one submitted in Mexico.

Applications generally require:

  • proof of foreign marketing authorization
  • technical documentation and risk analysis
  • evidence of Good Manufacturing Practices
  • labeling compliant with Mexican regulations
  • administrative documentation for the local registration holder

If the device differs from the product authorized in the reference jurisdiction, COFEPRIS may require the application to proceed through the standard registration route.

Strategic implications for companies entering Mexico

Mexico represents one of the largest and fastest-growing healthcare markets in Latin America, making accelerated regulatory approval particularly valuable for medical device manufacturers.

For companies already authorized in major markets such as the United States or the European Union, the fast-track pathway can:

  • significantly reduce time-to-market
  • simplify regulatory submissions
  • accelerate commercial expansion into Mexico

Manufacturers seeking to expand in the region should also consider how their regulatory strategy in Mexico aligns with broader Latin American market access plans, including countries such as Brazil, Colombia, or Peru.

Mandala International supports manufacturers in navigating the Mexican regulatory framework, including fast-track and standard medical device registration with COFEPRIS. Learn more about our expertise in health product registration and regulatory compliance in Mexico.

Official sources

Related Posts